Masaki Kitajima
- Surgery top 2%
- Oncology top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Co-authors
- Tetsuro KubotaSeiichiro IshiiToshiharu FurukawaYoshito ArisawaKatsuhiko NogaMasahiro OhgamiMasakazu UedaSoji Ozawa
- Topics
- Gastric Cancer Management and Outcomes (24 papers)Colorectal Cancer Treatments and Studies (16 papers)Lung Cancer Treatments and Mutations (12 papers)
- Cited by
- OncologySurgeryBiotechnology
- Partner nations
- JapanUnited StatesTunisia
In The Last Decade
Masaki Kitajima
136 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 133
- Surgery 1.2k
- Oncology 855
- Molecular Biology 624
- Pulmonary and Respiratory Medicine 453
- Cancer Research 318
Countries citing papers authored by Masaki Kitajima
This map shows the geographic impact of Masaki Kitajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaki Kitajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaki Kitajima more than expected).
Fields of papers citing papers by Masaki Kitajima
This network shows the impact of papers produced by Masaki Kitajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaki Kitajima. The network helps show where Masaki Kitajima may publish in the future.
Co-authorship network of co-authors of Masaki Kitajima
This figure shows the co-authorship network connecting the top 25 collaborators of Masaki Kitajima. A scholar is included among the top collaborators of Masaki Kitajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaki Kitajima. Masaki Kitajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 16 | |
| 4 | 26 | |
| 5 | Combination chemotherapy with JTE-522, a novel selective cyclooxygenase-2 inhibitor, and cisplatin against gastric cancer cell lines in vitro and in vivo. | 13 |
| 6 | 1 | |
| 7 | 0 | |
| 8 | 0 | |
| 9 | 2 | |
| 10 | 19 | |
| 11 | [Neoadjuvant chemotherapy and chemoradiotherapy in the treatment of esophageal cancer]. | 6 |
| 12 | 1 | |
| 13 | [Clinical evaluation of ErbB-2 protein in tissue extract using an enzyme immuno assay (ErbB-2 EIA "Nichirei")]. | 5 |
| 14 | [Clinical evaluation of serum ErbB-2 protein using enzyme immuno assay (ErbB-2 EIA [Nichirei])]. | 5 |
| 15 | 31 | |
| 16 | [High clinical predictability of histoculture drug response assay (HDRA) for drug-sensitivity of cancer of the digestive organs]. | 3 |
| 17 | 23 | |
| 18 | 4 | |
| 19 | 1 | |
| 20 | 3 |
About Masaki Kitajima
Masaki Kitajima is a scholar working on Oncology, Gastroenterology and Pulmonary and Respiratory Medicine, having authored 151 papers that have together received 2.7k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (24 papers), Colorectal Cancer Treatments and Studies (16 papers) and Lung Cancer Treatments and Mutations (12 papers). The work is most often cited by research in Oncology (855 citations), Surgery (1.2k citations) and Biotechnology (189 citations). Masaki Kitajima has collaborated with scholars based in Japan, United States and Tunisia. Frequent co-authors include Tetsuro Kubota, Seiichiro Ishii, Toshiharu Furukawa, Yoshito Arisawa, Katsuhiko Noga, Masahiro Ohgami, Masakazu Ueda, Soji Ozawa, Richard M. Hoffman and Masahiko Watanabe. Their work appears in journals such as The Journal of Immunology, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.